Quercetin PK/PD Study in Healthy Adults and Patients With Hypercoagulable States

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions

Healthy

Interventions

DRUG

isoquercetin or quercetin

Single dose PK/PD study

Trial Locations (1)

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors

lead

Beth Israel Deaconess Medical Center

OTHER

NCT01722669 - Quercetin PK/PD Study in Healthy Adults and Patients With Hypercoagulable States | Biotech Hunter | Biotech Hunter